GSK Investigational Site

Belém 66.073-005

1 studies enrolling now · 2 studies all time

What they study most

Colonic Neoplasms, Lung Cancer, Non-Small Cell, Neoplasms, Colon

Studies at this site

• Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer — Recruiting now
• A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC) — Running, not enrolling